Long noncoding RNAs (lncRNAs) are RNAs longer than 200 nt in length that are characterized by low levels of sequence conservation and expression; lncRNAs modulate various biological functions at epigenetic, transcriptional and post-transcriptional levels, or directly regulate protein activity. As a family of small and evolutionarily conserved noncoding RNAs, microRNAs (miRNAs) are capable of regulating physiological and pathological processes via inhibiting target mRNA translation or promoting mRNA degradation. A number of studies have confirmed that both lncRNAs and miRNAs are closely associated with the development of cardiovascular diseases (CVDs), such as cardiac remodelling, heart failure, myocardial injury and arrhythmia, and that they act as biomarkers, potential therapeutic targets or strong indicators of prognosis; however, the underlying molecular mechanism has not been elucidated. Recently, emerging evidence showed that the novel regulatory mechanism underlying the crosstalk among lncRNAs, miRNAs and mRNAs plays a pivotal role in the pathophysiological processes of CVDs in response to stress stimuli. In this review, I comprehensively summarized the regulatory relationship of lncRNAs, miRNAs and mRNAs and highlighted the important role of the lncRNA-miRNA-mRNA axis in CVDs.
greater that 200 nt, and some have a poly (A) tail. According to the NONCODE database (http://www.noncode.org), there are 102 783, 87 553 and 27 793 lncRNA genes for human, mouse and rat, respectively; in comparison, human have 19 836 human protein-coding genes (Ensemble 90). Alternative splicing during differentiation causes lncRNAs to exhibit lower levels of sequence conservation and expression than protein-coding genes, but growing evidence has confirmed that lncRNAs maintain pivotal and multiple functions in a vast array of biological processes despite their limited expression levels. To date, multiple lncRNAs have been well documented due to the development of high-throughput RNA sequencing (RNA-seq) techniques; they can be divided into five subclasses as sense, antisense, bidirectional, intergenic and intronic lncRNAs, based on their position in the genome or relation to the coding gene. 9 Functional analysis showed that lncRNAs could regulate genes expression at epigenetic, 10 transcriptional 11 and post-transcriptional levels, 12 or could directly modulate protein activity. 13 Unlike lncRNAs, miRNAs are a family of evolutionarily conserved, endogenous, ncRNAs approximately 22 nt in length, that can bind to the 3′-untranslated region (3′-UTR) of mRNAs through imperfect complementarity.
14 miRNAs may regulate more than 30% of genes and play a significant role in the regulation of biological activities in cells by inhibiting target mRNA translation or promoting mRNA degradation. 15, 16 It is of note that lncRNA and miRNA can modulate the initiation and progression of CVDs via regulating different molecular mechanisms. For instance, the inhibition of Meg3 suppressed cardiac fibrosis and hypertrophy by decreasing MMP-2 expression. 17 The up-regulation of miR-29 could reduce lesion size and necrotic zones via targeting Col1A and Col3A. 18 Recently, a novel regulatory mechanism among lncRNAs, miRNAs and their mRNA targets has been annotated in CVDs by pull-down assay, chromatin immunoprecipitation (ChIP), luciferase reporter gene assay and quantitative reverse transcription polymerase chain reaction (qRT-PCR) methods, although a plurality of evidence has revealed that lncRNA-miRNAmRNA cascades participated in various pathophysiological processes in the field of oncology. 7, [19] [20] [21] In this review, four kinds of regulatory 
| lncRNA AS miRNA SPONGES IN REGULATING THE BIOLOGICAL ACTIVITIES OF CARDIOMYOCYTE S AND CARDIAC FIBROBLASTS
In 2014, the lncRNA AK048451, named cardiac hypertrophy related factor (CHRF), was first identified as an endogenous sponge of miR-489 that could directly bind to miR-489 in a sequence-specific manner and restrain miR-489 expression; this ability was demonstrated by analysis with the bioinformatics programme RNA hybrid, luciferase reporter gene activity assay and pull-down assay. The enforced expression of CHRF promoted hypertrophic responses, and the inhibition of CHRF retarded cardiac hypertrophic effects induced by angiotensin II (Ang II) treatment by regulating the miR-489 activity and the expression of its target, myeloid differentiation primary response (Myd88); these effects suggested that CHRF served as the upstream negative regulator of the miR-489/Myd88 axis under the hypertrophic condition. 22 Other lncRNAs have also been confirmed to act as miRNA sponge in order to modulate cardiomyocyte hypertrophy. The lncRNA growth arrest-specific 5 (GAS5) was generally regarded as a tumour suppressor, acting as a miR-21 sponge, that could inhibit the proliferation and promote the apoptosis of various cancer cells. 23, 24 Interestingly, the study showed that GAS5 contained a binding site for miR-23a and acted as a sponge of miR-23a.
Up-regulated GAS5 expression inhibited cardiomyocyte hypertrophy through negatively regulating miR-23a and its target forkhead box O3 (Foxo3a). 25 Additionally, a previous study confirmed that myocardial infarction-associated transcript (MIAT) possessed binding sites for miR-150 and could serve as a miR-150 sponge in modulating cell proliferation, apoptosis and migration. 26 In cultured H9C2 cells, the overexpression of MIAT triggered an Ang II-induced hypertrophic response via inhibiting the level of miR-150 level; however, the possible target of miR-150 was not identified in this study. 27 Mitochondrial fission and fusion are associated with cardiomyocyte apoptosis. 28 The lncRNA AK017121, named cardiac apoptosis-related Cardiomyocyte necrosis mainly contributes to heart failure, while the underlying mechanism is not fully explained. 58 Second, the same lncRNA-miRNA-mRNA axis may modulate diverse biological functions in different diseases. The GAS5-miR-21-PTEN axis suppressed breast cancer cell proliferation 23 and increased the chemo-sensitivity of nonsmall cell lung cancer cells to cisplatin. 59 The CHRF-miR-489-Myd88 axis was also capable of triggering the development of pulmonary fibrosis. 60 Third, lncRNAs, miRNAs and mRNAs can be influenced by other molecules in response to stress conditions, which makes it difficult to fully explore the intrinsic regulatory mechanisms.
Finally, many studies have shown that the altered expression of lncRNAs and miRNAs has identified these lncRNAs and miRNAs as potential therapeutic targets or biomarkers in the progression of CVDs. 61, 62 However, owing to the lack of large-scale clinical studies, little is known about whether the dynamic regulation of the lncRNA-miRNA-mRNA axis could be viewed as the effect of drug therapy or as the marker of disease development. Collectively, the crosstalk among lncRNAs, miRNAs and mRNAs seems to be complex. I have summarized four kinds of regulatory relationships among these players under stress conditions (Table 1) ; however, the journey of exploring the function and mechanism of the lncRNA-miRNA-mRNA axis in the regulation of cardiovascular physiology and pathology remains long.
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